{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:14:17Z","timestamp":1762460057233,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10461-021-03529-w","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T18:02:27Z","timestamp":1636999347000},"page":"1808-1820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Latent Class Analysis of Sexual Behaviours and Attitudes to Sexually Transmitted Infections Among Gay and Bisexual Men Using PrEP"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3452-350X","authenticated-orcid":false,"given":"Michael W.","family":"Traeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen E.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Asselin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent J.","family":"Cornelisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna L.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret E.","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwina J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Stoov\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"3529_CR1","volume-title":"viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2018","author":"HIV Kirby Institute","year":"2018","unstructured":"Kirby Institute HIV. viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2018. Sydney: Kirby Institute; 2018."},{"issue":"5","key":"3529_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1071\/SH18097","volume":"16","author":"D Callander","year":"2019","unstructured":"Callander D, Guy R, Fairley CK, et al. Gonorrhoea gone wild: rising incidence of gonorrhoea and associated risk factors among gay and bisexual men attending Australian sexual health clinics. Sex Health. 2019;16(5):457\u201363.","journal-title":"Sex Health"},{"key":"3529_CR3","volume-title":"Gay community periodic survey: Melbourne 2018","author":"E Lee","year":"2018","unstructured":"Lee E, Mao L, Broady T, Bavinton B, McKenzie T, Batrouney C, Malholtra S, Manwaring J, West M, Prestage G, Holt M. Gay community periodic survey: Melbourne 2018. Sydney: Centre for Social Research in Health, UNSW Sydney; 2018."},{"issue":"8","key":"3529_CR4","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1016\/S2352-3018(18)30072-9","volume":"5","author":"M Holt","year":"2018","unstructured":"Holt M, Lea T, Mao L, et al. Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013\u201317. Lancet HIV. 2018;5(8):e448\u201356.","journal-title":"Lancet HIV"},{"key":"3529_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fpubh.2018.00151","volume":"6","author":"KE Ryan","year":"2018","unstructured":"Ryan KE, Mak A, Stoov\u00e9 M, et al. Protocol for an HIV pre-exposure prophylaxis (PrEP) population level intervention study in Victoria Australia: the PrEPX Study. Front Public Health. 2018;6:151.","journal-title":"Front Public Health"},{"issue":"11","key":"3529_CR6","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","volume":"5","author":"AE Grulich","year":"2018","unstructured":"Grulich AE, Guy R, Amin J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629\u201337.","journal-title":"Lancet HIV"},{"key":"3529_CR7","unstructured":"PBAC. December 2017 PBAC meeting\u2014positive recommendations. PBAC; 2017. http:\/\/www.pbs.gov.au\/industry\/listing\/elements\/pbac-meetings\/pbac-outcomes\/2017-12\/positive-recommendations-12-2017.pdf. Accessed 15 Oct 2020."},{"key":"3529_CR8","volume-title":"The Kirby Institute, monitoring HIV pre-exposure prophylaxis uptake in Australia (Issue 3)","author":"N Medland","year":"2020","unstructured":"Medland N. The Kirby Institute, monitoring HIV pre-exposure prophylaxis uptake in Australia (Issue 3). Sydney: The Kirby Institute, UNSW Sydney; 2020."},{"issue":"14","key":"3529_CR9","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1001\/jama.2019.2947","volume":"321","author":"MW Traeger","year":"2019","unstructured":"Traeger MW, Cornelisse VJ, Asselin J, et al. Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection. JAMA. 2019;321(14):1380\u201390.","journal-title":"JAMA"},{"issue":"1","key":"3529_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/sextrans-2016-052983","volume":"94","author":"J Datta","year":"2018","unstructured":"Datta J, Reid D, Hughes G, Mercer CH, Wayal S, Weatherburn P. Places and people: the perceptions of men who have sex with men concerning STI testing: a qualitative study. Sex Transm Infect. 2018;94(1):46\u201350.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"3529_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1071\/SH09117","volume":"7","author":"M Holt","year":"2010","unstructured":"Holt M, Bernard D, Race K. Gay men\u2019s perceptions of sexually transmissible infections and their experiences of diagnosis: \u2018part of the way of life\u2019 to feeling \u2018dirty and ashamed.\u2019 Sex Health. 2010;7(4):411\u20136.","journal-title":"Sex Health"},{"key":"3529_CR12","volume-title":"\u2018My Sex, My Sexual Health\u2019: a social study of sexually transmissible infections among gay and bisexual men","author":"D Callander","year":"2019","unstructured":"Callander D, Philpot S, Mao L, et al. \u2018My Sex, My Sexual Health\u2019: a social study of sexually transmissible infections among gay and bisexual men. Sydney: The Kirby Institute, UNSW Sydney; 2019."},{"issue":"5","key":"3529_CR13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciy182","volume":"67","author":"MW Traeger","year":"2018","unstructured":"Traeger MW, Schroeder SE, Wright EJ, et al. Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018;67(5):676\u201386.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"3529_CR14","doi-asserted-by":"publisher","first-page":"e1917134","DOI":"10.1001\/jamanetworkopen.2019.17134","volume":"2","author":"JJ Ong","year":"2019","unstructured":"Ong JJ, Baggaley RC, Wi TE, et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(12):e1917134.","journal-title":"JAMA Netw Open"},{"issue":"14","key":"3529_CR15","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/QAD.0000000000001185","volume":"30","author":"N Kojima","year":"2016","unstructured":"Kojima N, Davey DJ, Klausner JD. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS. 2016;30(14):2251\u20132.","journal-title":"AIDS"},{"issue":"11","key":"3529_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/apc.2015.0113","volume":"29","author":"PA Chan","year":"2015","unstructured":"Chan PA, Rose J, Maher J, et al. A latent class analysis of risk factors for acquiring HIV among men who have sex with men: implications for implementing pre-exposure prophylaxis programs. AIDS Patient Care STDS. 2015;29(11):597\u2013605.","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"3529_CR17","doi-asserted-by":"publisher","first-page":"e0221558","DOI":"10.1371\/journal.pone.0221558","volume":"14","author":"R Patrick","year":"2019","unstructured":"Patrick R, Jain J, Harvey-Vera A, et al. Perceived barriers to pre-exposure prophylaxis use among HIV-negative men who have sex with men in Tijuana, Mexico: a latent class analysis. PLoS ONE. 2019;14(8):e0221558.","journal-title":"PLoS ONE"},{"issue":"1","key":"3529_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/sextrans-2019-053977","volume":"96","author":"IAL Slurink","year":"2019","unstructured":"Slurink IAL, van Benthem BHB, van Rooijen MS, Achterbergh RCA, van Aar F. Latent classes of sexual risk and corresponding STI and HIV positivity among MSM attending centres for sexual health in the Netherlands. Sex Transm Infect. 2019;96(1):33\u20139.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"3529_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/sextrans-2017-053375","volume":"94","author":"AL Wilkinson","year":"2017","unstructured":"Wilkinson AL, Draper BL, Pedrana AE, et al. Measuring and understanding the attitudes of Australian gay and bisexual men towards biomedical HIV prevention using cross-sectional data and factor analyses. Sex Transm Infect. 2017;94(4):309\u201314.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"3529_CR20","first-page":"269","volume":"25","author":"CM Doyle","year":"2020","unstructured":"Doyle CM, Maheu-Giroux M, Lambert G, et al. Combination HIV prevention strategies among Montreal gay, bisexual, and other men who have sex with men in the PrEP era: a latent class analysis. AIDS Behav. 2020;25(2):269\u201383.","journal-title":"AIDS Behav"},{"issue":"6","key":"3529_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1177\/0956462419899012","volume":"31","author":"DT Dangerfield II","year":"2020","unstructured":"Dangerfield DT II, Carmack CC, Gilreath TD, Duncan DT. Latent classes of partner-seeking venues and sexual risk among men who have sex with men in Paris, France. Int J STD AIDS. 2020;31(6):502\u20139.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"3529_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/add.14774","volume":"115","author":"RCA Achterbergh","year":"2020","unstructured":"Achterbergh RCA, de Vries HJC, Boyd A, et al. Identification and characterization of latent classes based on drug use among men who have sex with men at risk of sexually transmitted infections in Amsterdam, The Netherlands. Addiction. 2020;115(1):121\u201333.","journal-title":"Addiction"},{"issue":"2","key":"3529_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"3529_CR24","volume-title":"2018 It\u2019s Your Love Life periodic survey: sexual health promotion needs of heterosexually-identified young people in NSW","author":"PCG Adam","year":"2018","unstructured":"Adam PCG, de Wit JBF, Janssen M, et al. 2018 It\u2019s Your Love Life periodic survey: sexual health promotion needs of heterosexually-identified young people in NSW. Sydney: UNSW Centre for Social Research in Health; 2018."},{"issue":"8","key":"3529_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/sextrans-2015-052052","volume":"91","author":"A Bourne","year":"2015","unstructured":"Bourne A, Reid D, Hickson F, Torres-Rueda S, Weatherburn P. Illicit drug use in sexual settings (\u2018chemsex\u2019) and HIV\/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2015;91(8):564\u20138.","journal-title":"Sex Transm Infect"},{"key":"3529_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.drugpo.2017.01.001","volume":"43","author":"J Sewell","year":"2017","unstructured":"Sewell J, Miltz A, Lampe FC, et al. Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. Int J Drug Policy. 2017;43:33\u201343.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"3529_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/hiv.12574","volume":"19","author":"EL Pufall","year":"2018","unstructured":"Pufall EL, Kall M, Shahmanesh M, et al. Sexualized drug use (\u2018chemsex\u2019) and high-risk sexual behaviours in HIV-positive men who have sex with men. HIV Med. 2018;19(4):261\u201370.","journal-title":"HIV Med"},{"key":"3529_CR28","volume-title":"Latent class analysis: the empirical study of latent types, latent variables, and latent structures","author":"LA Goodman","year":"2002","unstructured":"Goodman LA. Latent class analysis: the empirical study of latent types, latent variables, and latent structures. Cambridge: Cambridge University Press; 2002."},{"issue":"2","key":"3529_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11121-011-0201-1","volume":"14","author":"ST Lanza","year":"2013","unstructured":"Lanza ST, Rhoades BL. Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment. Prev Sci. 2013;14(2):157\u201368.","journal-title":"Prev Sci"},{"key":"3529_CR30","unstructured":"StataCorp LP. STATA structural equation modeling reference manual. Release 13. College Station: StataCorp LP."},{"issue":"11","key":"3529_CR31","doi-asserted-by":"publisher","first-page":"e11028","DOI":"10.2196\/11028","volume":"7","author":"D Callander","year":"2018","unstructured":"Callander D, Moreira C, El-Hayek C, et al. Monitoring the control of sexually transmissible infections and blood-borne viruses: protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS). JMIR Res Protoc. 2018;7(11):e11028.","journal-title":"JMIR Res Protoc"},{"issue":"6","key":"3529_CR32","doi-asserted-by":"publisher","first-page":"e16757","DOI":"10.2196\/16757","volume":"22","author":"L Nguyen","year":"2020","unstructured":"Nguyen L, Stoove M, Boyle D, et al. Privacy-preserving record linkage of deidentified records within a public health surveillance system: evaluation study. J Med Internet Res. 2020;22(6):e16757.","journal-title":"J Med Internet Res"},{"issue":"3","key":"3529_CR33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","volume":"18","author":"J-M Molina","year":"2018","unstructured":"Molina J-M, Charreau I, Chidiac C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018;18(3):308\u201317.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"3529_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/OLQ.0000000000000216","volume":"42","author":"RK Bolan","year":"2015","unstructured":"Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis. 2015;42(2):98\u2013103.","journal-title":"Sex Transm Dis"},{"key":"3529_CR35","unstructured":"Australian New Zealand Trial Registry. MenGO: does the licensed meningococcal vaccine Bexsero\u00ae provide cross- protection against gonorrhoea? https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=376715. Accessed 28 May 2020."},{"issue":"2","key":"3529_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/QAI.0000000000002232","volume":"83","author":"P Keen","year":"2020","unstructured":"Keen P, Hammoud MA, Bourne A, et al. Use of HIV pre-exposure prophylaxis (PrEP) associated with lower HIV anxiety among gay and bisexual men in Australia who are at high risk of HIV infection: results from the flux study. J Acquir Immune Defic Syndr. 2020;83(2):119\u201325.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3529_CR37","volume-title":"Gay community periodic survey: Melbourne 2020","author":"T Broady","year":"2020","unstructured":"Broady T, Chan C, Bavinton B, et al. Gay community periodic survey: Melbourne 2020. Sydney: UNSW Centre for Social Research in Health; 2020."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03529-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03529-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03529-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T11:04:48Z","timestamp":1651057488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03529-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3529"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03529-w","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"23 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MWT received speaker\u2019s fees from Gilead Sciences. DM received grants from Alfred Health. VJC has received speaker\u2019s fees and conference assistance from Gilead Sciences and advisory board fees from ViiV Healthcare. EJW reports receipt of grants from the Victorian, Tasmanian and the South Australian governments for PrEPX; other from Gilead Sciences compensation to her institution for chairing a nursing education session and for attending an advisory board meeting, and uncompensated attendance for attending 2 Gilead meetings regarding listing of Truvada on the Australian pharmaceutical benefits scheme); grants from, Gilead Science and Merck Sharp and Dohme outside the submitted work; and financial support from, Gilead Sciences, Abbott Laboratories, Janssen-Cilag, Boehringer Ingelheim, ViiV Healthcare, and Merck Sharp and Dohme. MH received grants from the Australian Department of Health, Gilead Sciences, Abbvie and Bristol Myers-Squibb. JA received grants from the Australian Government\u2019s Department of Health. MS received a research fellowship from the National Health and Medical Research Council, and investigator-initiated grants from Gilead Sciences and Bristol-Myers-Squibb. All other authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The PrEPX study was approved by the Alfred Health Human Research and Ethics Committee (HREC100\/16) and registered on the Australian New Zealand Clinical Trials Registry (ACTRN12616001215415). Ethics approval for the ACCESS Project in Victoria was provided by the Alfred Hospital Human Research Ethics Committee (Project 248\/17), as well as several specialised committees for key populations, including ACON, Thorne Harbour Health, and the Aboriginal Health and Medical Research Council.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individuals in the PrEPX study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}